MedTrace Logo

Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation

NCT05950971 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2023-07-18

No results posted yet for this study

Summary

Adult patients who are diagnosed new onset atrial fibrillation with rapid ventricular response within 7 days after non-cardiac non-thoracic surgery are enrolled.

Conditions

  • Atrial Fibrillation New Onset
  • Atrial Fibrillation Paroxysmal

Interventions

DRUG

Amiodarone, diltiazem or esmolol

Intravenous continuous infusion after loading or bolus dose of amiodarone, diltiazem or esmolol.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hogeol Ryu · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-01-21
Completion
2022-01-21

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950971 on ClinicalTrials.gov